Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
2826
LENZ Therapeutics
LENZ
$161M
| $559K | ﹤0.01% |
32,600
-14,525
| -31% | -$235K |
|
2827
Electromed
ELMD
$348M
| $556K | ﹤0.01% |
53,504
+10,700
| +25% | +$121K |
|
2828
Nortech Systems
NSYS
$38.7M
| $554K | ﹤0.01% |
52,059
-1,100
| -2% | -$14.7K |
|
2829
Usio Inc
USIO
$61.8M
| $554K | ﹤0.01% |
318,141
-3,600
| -1% | -$6.63K |
|
2830
iShares MSCI Intl Value Factor ETF
IVLU
$4.46B
| $553K | ﹤0.01% |
22,300
+1,400
| +7% | +$34.4K |
|
2831
ROBO Global Robotics & Automation Index ETF
ROBO
$2B
| $553K | ﹤0.01% |
+10,100
| New | +$527K |
|
|
SUM
2832
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $552K | ﹤0.01% |
+19,378
| New | +$586K |
|
2833
VanEck Pharmaceutical ETF
PPH
$918M
| $551K | ﹤0.01% |
+7,100
| New | +$547K |
|
2834
Cardiff Oncology
CRDF
$68.2M
| $547K | ﹤0.01% |
331,308
-159,682
| -33% | -$274K |
|
2835
Deluxe
DLX
$1.23B
| $547K | ﹤0.01% |
34,200
+5,500
| +19% | +$100K |
|
2836
M-tron Industries
MPTI
$358M
| $547K | ﹤0.01% |
50,913
-27,200
| -35% | -$276K |
|
2837
Stoke Therapeutics
STOK
$1.82B
| $547K | ﹤0.01% |
65,700
-38,900
| -37% | -$351K |
|
2838
iShares US Healthcare ETF
IYH
$3.44B
| $546K | ﹤0.01% |
10,000
-500
| -5% | -$27.4K |
|
|
ONT
2839
Onterris Inc
ONT
$779M
| $546K | ﹤0.01% |
+15,300
| New | +$693K |
|
2840
SEACOR Marine Holdings
SMHI
$256M
| $545K | ﹤0.01% |
71,600
+3,900
| +6% | +$37.1K |
|
2841
Willamette Valley Vineyards
WVVI
$12.7M
| $545K | ﹤0.01% |
90,152
-2,200
| -2% | -$13.6K |
|
|
OPOF
2842
DELISTED
Old Point Financial
OPOF
| $544K | ﹤0.01% |
22,835
-900
| -4% | -$22.5K |
|
2843
Prudential
PUK
$37.3B
| $544K | ﹤0.01% |
19,900
-66,100
| -77% | -$1.99M |
|
|
LGF.B
2844
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $544K | ﹤0.01% |
52,439
-236,500
| -82% | -$2.01M |
|
2845
GEE Group
JOB
$23.4M
| $540K | ﹤0.01% |
1,301,000
-253,900
| -16% | -$115K |
|
2846
Invesco Aerospace & Defense ETF
PPA
$8.41B
| $540K | ﹤0.01% |
+6,700
| New | +$534K |
|
2847
Instil Bio
TIL
$48.4M
| $540K | ﹤0.01% |
40,866
-23,355
| -36% | -$345K |
|
2848
Capital Group Dividend Value ETF
CGDV
$38B
| $539K | ﹤0.01% |
+21,600
| New | +$529K |
|
|
AKTS
2849
DELISTED
Akoustis Technologies Inc
AKTS
| $539K | ﹤0.01% |
+175,129
| New | +$611K |
|
2850
ProShares Short High Yield
SJB
$47.9M
| $538K | ﹤0.01% |
29,307
+11,407
| +64% | +$213K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.